Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kai-Rong Zhu"'
Autor:
Yu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, Bin-Song Mu, Yang Zheng, Meng-Yi Huang, Cong Zhou, Wen-Fang Li, Zhenling Wang, Yong Wu, Guo-Bo Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbafd46ed05e2ed19d6bd52895cbdda
https://doi.org/10.2139/ssrn.4379430
https://doi.org/10.2139/ssrn.4379430
Autor:
Ji Deng, Ze-Min Liu, Kai-Rong Zhu, Gui-Ling Cui, Lin-Xia Liu, Yu-Hang Yan, Xiang-Li Ning, Zhu-Jun Yu, Guo-Bo Li, Qing-Rong Qi
Publikováno v:
Bioorganic Chemistry. 135:106487
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7c28513d62c0d4c426772df0fa7e050
https://doi.org/10.1016/j.bioorg.2023.106487
https://doi.org/10.1016/j.bioorg.2023.106487
Autor:
Gen Li, Xiao-Pan Chen, Yu-Hang Yan, Ji Deng, Jürgen Brem, Christopher J. Schofield, You-Cai Xiao, Kai-Rong Zhu, Guo-Bo Li, Fener Chen, Jun-Lin Yu
Publikováno v:
Chemical Communications (Cambridge, England)
Chiral 3-substituted benzoxaboroles were designed as carbapenemase inhibitors and efficiently synthesised via asymmetric Morita–Baylis–Hillman reaction. Some of the benzoxaboroles were potent inhibitors of clinically relevant carbapenemases and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc40948ed7a3411e56653217f9b24f5
https://doi.org/10.1039/d1cc03026d
https://doi.org/10.1039/d1cc03026d
Autor:
Yang Lingling, Zhenling Wang, Ji Deng, Kai-Rong Zhu, Chao Li, Guo-Bo Li, Wenfang Li, Qing-Qing Dai, Yu-Hang Yan, Wei Chen
Publikováno v:
European journal of medicinal chemistry. 228
Production of metallo-β-lactamases (MBLs) in bacterial pathogens is an important cause of resistance to the ‘last-resort’ carbapenem antibiotics. Development of effective MBL inhibitors to reverse carbapenem resistance in Gram-negative bacteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f672fd532dfb6b1219d5668b2b9d098
https://pubmed.ncbi.nlm.nih.gov/34763944
https://pubmed.ncbi.nlm.nih.gov/34763944
Autor:
Yong Wu, Ji Deng, Si-Yao Wang, Zong-Yuan Luo, Yali Ren, Yu-Xiang Wu, Cui Huo, Kai-Rong Zhu, Cheng Gao, Guo-Bo Li, Xiang-Li Ning, Jun-Lin Yu, Chen Yang, Shan Qian, Miao Wang, Gen Li, Zhouyu Wang, Cheng Peng, Yang Lingling, Yuzhi Li
Publikováno v:
Journal of medicinal chemistry. 64(12)
Human indoleamine 2,3-dioxygenase 1 (hIDO1) and tryptophan 2,3-dioxygenase (hTDO) have been closely linked to the pathogenesis of Parkinson's disease (PD); nevertheless, development of dual hIDO1 and hTDO inhibitors to evaluate their potential effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f340a3108bdb57246c8a632ec81839ca
https://pubmed.ncbi.nlm.nih.gov/34110158
https://pubmed.ncbi.nlm.nih.gov/34110158